Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions

The DCB-only All-Comers Registry

Mark Rosenberg, Matthias Waliszewski, Kenneth Chin, Wan Azman Wan Ahmad, Giuseppe Caramanno, Diego Milazzo, Amin Ariff Nuruddin, Houng Bang Liew, Oteh Maskon, Pierre Aubry, Raphael Poyet, Norbert Frey

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objectives: This prospective, observational all-comers registry assessed the safety and efficacy of a Drug Coated Balloon-only strategy (DCB-only) in patients with coronary lesions. Background: Data regarding the performance of a DCB-only approach, especially in patients with previously untreated de-novo coronary artery disease (CAD), are still limited. Methods: This study was conducted as an international, multicenter registry primarily enrolling patients with de-novo CAD. However, it was also possible to include patients with in-stent restenosis (ISR). The primary endpoint was the rate of clinically driven target lesion revascularization (TLR) after 9 months. Results: A total of 1,025 patients with a mean age of 64.0 ± 11.2 years were enrolled. The majority of treated lesions were de-novo (66.9%), followed by drug-eluting-stent ISR (DES-ISR; 22.6%) and bare-metal-stent ISR (BMS-ISR; 10.5%). The TLR rate was lower in the de-novo group (2.3%) when compared to BMS- (2.9%) and DES-ISR (5.8%) (P = 0.049). Regarding MACE, there was a trend toward fewer events in the de-novo group (5.6%) than in the BMS- (7.8%) and DES-ISR cohort (9.6%) (P = 0.131). Subgroup analyses revealed that lesion type (95% CI 1.127–6.587); P = 0.026) and additional stent implantation (95% CI 0.054–0.464; P = 0.001) were associated with higher TLR rates. Conclusions: Our results show that DCB-only angioplasty of de-novo coronary lesions is associated with low MACE and TLR rates. Thus, DCBs appear to be an attractive alternative for the interventional, stentless treatment of suitable de-novo coronary lesions.

Original languageEnglish
JournalCatheterization and Cardiovascular Interventions
DOIs
Publication statusAccepted/In press - 1 Jan 2018

Fingerprint

Multicenter Studies
Stents
Registries
Pharmaceutical Preparations
Coronary Artery Disease
Drug-Eluting Stents
Angioplasty
Metals
Safety

Keywords

  • coronary intervention
  • devices
  • MACE
  • TLR
  • tools

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions : The DCB-only All-Comers Registry. / Rosenberg, Mark; Waliszewski, Matthias; Chin, Kenneth; Ahmad, Wan Azman Wan; Caramanno, Giuseppe; Milazzo, Diego; Nuruddin, Amin Ariff; Liew, Houng Bang; Maskon, Oteh; Aubry, Pierre; Poyet, Raphael; Frey, Norbert.

In: Catheterization and Cardiovascular Interventions, 01.01.2018.

Research output: Contribution to journalArticle

Rosenberg, M, Waliszewski, M, Chin, K, Ahmad, WAW, Caramanno, G, Milazzo, D, Nuruddin, AA, Liew, HB, Maskon, O, Aubry, P, Poyet, R & Frey, N 2018, 'Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry', Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.27724
Rosenberg, Mark ; Waliszewski, Matthias ; Chin, Kenneth ; Ahmad, Wan Azman Wan ; Caramanno, Giuseppe ; Milazzo, Diego ; Nuruddin, Amin Ariff ; Liew, Houng Bang ; Maskon, Oteh ; Aubry, Pierre ; Poyet, Raphael ; Frey, Norbert. / Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions : The DCB-only All-Comers Registry. In: Catheterization and Cardiovascular Interventions. 2018.
@article{af7874ec2e844426bc84f554d9bf9071,
title = "Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions: The DCB-only All-Comers Registry",
abstract = "Objectives: This prospective, observational all-comers registry assessed the safety and efficacy of a Drug Coated Balloon-only strategy (DCB-only) in patients with coronary lesions. Background: Data regarding the performance of a DCB-only approach, especially in patients with previously untreated de-novo coronary artery disease (CAD), are still limited. Methods: This study was conducted as an international, multicenter registry primarily enrolling patients with de-novo CAD. However, it was also possible to include patients with in-stent restenosis (ISR). The primary endpoint was the rate of clinically driven target lesion revascularization (TLR) after 9 months. Results: A total of 1,025 patients with a mean age of 64.0 ± 11.2 years were enrolled. The majority of treated lesions were de-novo (66.9{\%}), followed by drug-eluting-stent ISR (DES-ISR; 22.6{\%}) and bare-metal-stent ISR (BMS-ISR; 10.5{\%}). The TLR rate was lower in the de-novo group (2.3{\%}) when compared to BMS- (2.9{\%}) and DES-ISR (5.8{\%}) (P = 0.049). Regarding MACE, there was a trend toward fewer events in the de-novo group (5.6{\%}) than in the BMS- (7.8{\%}) and DES-ISR cohort (9.6{\%}) (P = 0.131). Subgroup analyses revealed that lesion type (95{\%} CI 1.127–6.587); P = 0.026) and additional stent implantation (95{\%} CI 0.054–0.464; P = 0.001) were associated with higher TLR rates. Conclusions: Our results show that DCB-only angioplasty of de-novo coronary lesions is associated with low MACE and TLR rates. Thus, DCBs appear to be an attractive alternative for the interventional, stentless treatment of suitable de-novo coronary lesions.",
keywords = "coronary intervention, devices, MACE, TLR, tools",
author = "Mark Rosenberg and Matthias Waliszewski and Kenneth Chin and Ahmad, {Wan Azman Wan} and Giuseppe Caramanno and Diego Milazzo and Nuruddin, {Amin Ariff} and Liew, {Houng Bang} and Oteh Maskon and Pierre Aubry and Raphael Poyet and Norbert Frey",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/ccd.27724",
language = "English",
journal = "Catheterization and Cardiovascular Interventions",
issn = "1522-1946",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Prospective, large-scale multicenter trial for the use of drug-coated balloons in coronary lesions

T2 - The DCB-only All-Comers Registry

AU - Rosenberg, Mark

AU - Waliszewski, Matthias

AU - Chin, Kenneth

AU - Ahmad, Wan Azman Wan

AU - Caramanno, Giuseppe

AU - Milazzo, Diego

AU - Nuruddin, Amin Ariff

AU - Liew, Houng Bang

AU - Maskon, Oteh

AU - Aubry, Pierre

AU - Poyet, Raphael

AU - Frey, Norbert

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objectives: This prospective, observational all-comers registry assessed the safety and efficacy of a Drug Coated Balloon-only strategy (DCB-only) in patients with coronary lesions. Background: Data regarding the performance of a DCB-only approach, especially in patients with previously untreated de-novo coronary artery disease (CAD), are still limited. Methods: This study was conducted as an international, multicenter registry primarily enrolling patients with de-novo CAD. However, it was also possible to include patients with in-stent restenosis (ISR). The primary endpoint was the rate of clinically driven target lesion revascularization (TLR) after 9 months. Results: A total of 1,025 patients with a mean age of 64.0 ± 11.2 years were enrolled. The majority of treated lesions were de-novo (66.9%), followed by drug-eluting-stent ISR (DES-ISR; 22.6%) and bare-metal-stent ISR (BMS-ISR; 10.5%). The TLR rate was lower in the de-novo group (2.3%) when compared to BMS- (2.9%) and DES-ISR (5.8%) (P = 0.049). Regarding MACE, there was a trend toward fewer events in the de-novo group (5.6%) than in the BMS- (7.8%) and DES-ISR cohort (9.6%) (P = 0.131). Subgroup analyses revealed that lesion type (95% CI 1.127–6.587); P = 0.026) and additional stent implantation (95% CI 0.054–0.464; P = 0.001) were associated with higher TLR rates. Conclusions: Our results show that DCB-only angioplasty of de-novo coronary lesions is associated with low MACE and TLR rates. Thus, DCBs appear to be an attractive alternative for the interventional, stentless treatment of suitable de-novo coronary lesions.

AB - Objectives: This prospective, observational all-comers registry assessed the safety and efficacy of a Drug Coated Balloon-only strategy (DCB-only) in patients with coronary lesions. Background: Data regarding the performance of a DCB-only approach, especially in patients with previously untreated de-novo coronary artery disease (CAD), are still limited. Methods: This study was conducted as an international, multicenter registry primarily enrolling patients with de-novo CAD. However, it was also possible to include patients with in-stent restenosis (ISR). The primary endpoint was the rate of clinically driven target lesion revascularization (TLR) after 9 months. Results: A total of 1,025 patients with a mean age of 64.0 ± 11.2 years were enrolled. The majority of treated lesions were de-novo (66.9%), followed by drug-eluting-stent ISR (DES-ISR; 22.6%) and bare-metal-stent ISR (BMS-ISR; 10.5%). The TLR rate was lower in the de-novo group (2.3%) when compared to BMS- (2.9%) and DES-ISR (5.8%) (P = 0.049). Regarding MACE, there was a trend toward fewer events in the de-novo group (5.6%) than in the BMS- (7.8%) and DES-ISR cohort (9.6%) (P = 0.131). Subgroup analyses revealed that lesion type (95% CI 1.127–6.587); P = 0.026) and additional stent implantation (95% CI 0.054–0.464; P = 0.001) were associated with higher TLR rates. Conclusions: Our results show that DCB-only angioplasty of de-novo coronary lesions is associated with low MACE and TLR rates. Thus, DCBs appear to be an attractive alternative for the interventional, stentless treatment of suitable de-novo coronary lesions.

KW - coronary intervention

KW - devices

KW - MACE

KW - TLR

KW - tools

UR - http://www.scopus.com/inward/record.url?scp=85054329381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054329381&partnerID=8YFLogxK

U2 - 10.1002/ccd.27724

DO - 10.1002/ccd.27724

M3 - Article

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

SN - 1522-1946

ER -